Aerovate Therapeutics shares owned by Paradigm Biocapital Advisors
Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by Paradigm Biocapital Advisors
from 13F filings
Historical chart of Paradigm Biocapital Advisors investment in Aerovate Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aerovate Therapeutics held by Paradigm Biocapital Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aerovate Therapeutics by Paradigm Biocapital Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $3.2M | 143k | 22.63 |
More positions owned by Paradigm Biocapital Advisors
View all positions for Paradigm Biocapital Advisors